← Open Payments lookup

AMY ZECEVIC: Open Payments

NPI 1275173783 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,116 in 50 payments from 12 companies in 2025. Trend: 2023 $1,250 · 2024 $1,446 · 2025 $1,116

Food & beverage: $1,116
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$316
Teva Pharmaceuticals USA, Inc.8$142
Neurocrine BioSciences, Inc.7$140
Alkermes, Inc.6$117
Otsuka America Pharmaceutical, Inc.5$102
Axsome Therapeutics, Inc.3$87
ABBVIE INC.3$63
Lundbeck LLC2$51
Takeda Pharmaceuticals U.S.A., Inc.1$28
Vanda Pharmaceuticals Inc.1$28

Products named: CAPLYTA, REXULTI, AUSTEDO XR, INGREZZA, Auvelity, LYBALVI, VRAYLAR, ARISTADA.

Industry payments across FL — which companies pay providers there.